Qube Research & Technologies (QRT)
MRVI icon

Qube Research & Technologies (QRT)’s Maravai LifeSciences MRVI Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-805,954
Closed -$5.28M – 4728
2023
Q4 		$5.28M Buy
+805,954
New +$5.21M 0.01% 1006
2023
Q3 		– Sell
-89,934
Closed -$1.12M – 4249
2023
Q2 		$1.12M Sell
89,934
-891,223
-91% -$12M ﹤0.01% 1263
2023
Q1 		$13.7M Sell
981,157
-253,928
-21% -$3.65M 0.06% 360
2022
Q4 		$17.7M Buy
1,235,085
+1,182,684
+2,257% +$18.6M 0.09% 313
2022
Q3 		$1.34M Buy
52,401
+30,660
+141% +$769K 0.01% 1087
2022
Q2 		$618K Sell
21,741
-10,815
-33% -$343K ﹤0.01% 1320
2022
Q1 		$1.15M Sell
32,556
-79,027
-71% -$2.65M 0.01% 1103
2021
Q4 		$4.67M Buy
111,583
+67,774
+155% +$2.75M 0.04% 578
2021
Q3 		$2.15M Buy
43,809
+460
+1% +$22.4K 0.03% 654
2021
Q2 		$1.81M Sell
43,349
-3,487
-7% -$135K 0.02% 742
2021
Q1 		$1.67M Buy
46,836
+37,085
+380% +$1.23M 0.03% 675
2020
Q4 		$274K Buy
+9,751
New +$272K ﹤0.01% 1392

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MRVI Position: Q1 2024 in Review

Qube Research & Technologies (QRT) sold out of Maravai LifeSciences (MRVI) in Q1 2024, closing a stake of 805,954 shares — an estimated $5.28M sold.

Qube Research & Technologies (QRT) first reported a position in MRVI in Q4 2020 and held it in 12 quarters. The position peaked at $17.7M in Q4 2022. 210 funds tracked by Wall St. Rank hold MRVI as of Q1 2024.

  • Qube Research & Technologies (QRT) reported no remaining Maravai LifeSciences position as of Q1 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 805,954 Maravai LifeSciences shares in Q1 2024, an estimated $5.28M.
  • Qube Research & Technologies (QRT) first reported a position in Maravai LifeSciences in Q4 2020 and held it in 12 quarters.
  • Qube Research & Technologies (QRT)'s Maravai LifeSciences position peaked at $17.7M in Q4 2022.
  • 210 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2024, filed 14 May 2024.